Bijal Parikh, MD, PhD

Assistant Professor, Pathology & Immunology
Director, BJH Molecular Diagnostics Lab
Director, Molecular Genetic Pathology Fellowship



  • Laboratory & Genomic Medicine

Additional Titles

  • Associate Medical Director, Molecular Infectious Disease Laboratory
  • LGM Patient Safety and Quality Officer


  • BS: Rutgers University, New Brunswick, NJ (1998)
  • PhD: Rutgers University, New Brunswick, NJ (2004)
  • MD: Robert Wood Johnson Medical School-Rutgers University, Piscataway, NJ (2006)
  • Residency, Clinical Pathology: Washington University, St. Louis, MO (2010)
  • Fellowship, Molecular Genetic Pathology: Washington University, St. Louis, MO (2018)

Board Certifications

  • Missouri Medical License
  • American Board of Pathology in Clinical Pathology, 2011
  • American Board of Pathology in Molecular Genetic Pathology, 2019


  • Outstanding Research Award in Molecular Pathology/Pharmacogenomics, American Association for Clinical Chemistry Annual Meeting, 2009

  • Paul E. Strandjord Young Investigator Award, Academy of Clinical Laboratory Physicians and Scientists Annual Meeting, 2009, 2010

  • Chair’s Special Recognition Award, COVID Clinical Hero, Washington University Department of Pathology and Immunology, 2020

  • Outstanding Achievements in Quality Improvement Award, Washington University Department of Pathology and Immunology, 2020

  • Faculty Educator of the Year, Clinical Pathology, 2021-2022

Clinical Interests

  • Clinical virology
  • Molecular diagnostics
  • Next-generation sequencing
  • Molecular assay development

Research Interests

My clinical research centers on aspects of laboratory testing involving viral, immunologic, and molecular diagnostics, with a specific focus on the implementation of next-generation sequencing approaches. My translational research focus is the development of novel molecular diagnostics approaches for infectious disease testing.


Gupta R., Gupta P., Wang S., Seth A., Melnykov A., Jiang Q., Seth A., Wang Z., Morrissey J., George I., Gandra S., Sinha P., Storch G., Parikh B.A., Genin G., and Singamaneni S. Ultrasensitive lateral-flow assays via plasmonically active antibody-conjugated fluorescent nanoparticles. Nature BME. 2023 doi: 10.1038/s41551-022-01001-1. PMID: 36732621.
Hou Y.C., Evenson M.J., Corliss M.M., Mahapatra L., Aldawood A., Carpentieri D.F., Chamlin S.L., Kulungowski A.M., Madan-Khetarpal S., Sebastian J., Pet M.A., Coughlin C.C., Willing M.C., Pearson G.D., Setty B.A., El-Haffaf Z., Cottrell C.E., Parikh B.A., Krysiak K., Schroeder M.C., Heusel J.W., Neidich J.A., Cao Y. A Comparative Analysis of RAS Variants in Patients with Disorders of Somatic Mosaicism. Genet Med. 2022 Nov 29:S1098-3600(22)01036-X. doi: 10.1016/j.gim.2022.11.016. PMID: 36571464
Rodino K.G., Peaper D.R., Kelly B.J., Bushman F., Marques A., Adhikari H., Tu Z.J., Marrero Rolon R., Westblade L.F., Green D.A., Berry G.J., Wu F., Annavajhala M.K., Uhlemann A.C., Parikh B.A., McMillen T., Jani K., Babady N.E., Hahn A.M., Koch R.T., Grubaugh N.D.; Yale SARS-CoV-2 Genomic Surveillance Initiative, Rhoads D.D. Partial ORF1ab Gene Target Failure with Omicron BA.2.12.1. J Clin Microbiol. 2022 May 18:e0060022. doi: 10.1128/jcm.00600-22. PMID: 35582905
Saadalla A., Goldsmith S.R., Neidich J., Duncavage E., and Parikh B.A. IGHV somatic hypermutation testing in a patient with small lymphocytic lymphoma and multiple myeloma. J Appl Lab Med. 2021. 6(6):1665-1670. doi: 10.1093/jalm/jfab070. PMID: 34355767
Raju S., Anderson N.W., Robinson E., Squires C., Wallace M.A., Burnham C.D, and Parikh B.A. Comparison of Six SARS-CoV-2 Molecular Methods and Correlation with the Cycle Threshold Distribution in Clinical Specimens. J Appl Lab Med. 2021. 6(6):1452-1462. doi: 10.1093/jalm/jfab086. PMID: 34289054

Dionne Brierton
BJCIH Room 5800